Glaucoma is the leading cause of irreversible visual impairment worldwide. Because the disease often progresses without ...

In 2026, the FDA approved 23 brand-new medications never sold before in the U.S., covering everything from childhood genetic ...

(RGNX) tumbled 15% after-hours on Thursday after the company announced plans to raise $100 million through a public stock ...

Could this work to prevent blindness and eventually turn back the clock in other organs too?

Every living organism inherits a unique combination of traits, from eye colour and blood type to resistance against certain ...

Cell and gene therapies for degenerative eye diseases are still a long way off, but they have the potential to make a transformative difference to people’s lives. Vision impairment and loss caused by ...

A Pittsburgh-area man is participating in a clinical trial for a medication to treat Stargardt disease, a rare retinal ...

Today, as co-founder Steve Johnston celebrates his birthday, A Race Against Blindness marks another milestone: helping families facing inherited blindness. The Arizona-based nonprofit, founded by ...

Healome Therapeutics ('Healome'), a University of Birmingham spinout developing a proprietary eye-drop matrix technology for ocular surface diseases, has closed a GBP£2 million oversubscribed seed ...

MeiraGTx to receive up to $375 million in non-dilutive cash and up to $25 million in equity investmentFollowing regulatory approval, Oberland Capital to receive low single-digit capped royalties on ...

Night vision makes early signs of vision-related issues such as cataract more apparent, shares Dr Mounika Gadikota.